Cost-effectiveness of different treatment strategies for tuberculosis in Egypt and Syria


A. Vassall, S. Bagdadi, H. Bashour, H. Zaher, P.V. Maaren

TUBERCULOSIS (TB) is an increasing public health problem, presently accounting for 3% of global mortality.1 To tackle this problem, the World Health Organization (WHO) recommends the directly observed treatment, short course (DOTS) TB control strategy, which entails the use of short- course regimens of effective drug combinations, direct supervision of treatment for at least the first 2 months, and evaluation of treatment for each patient.2 As a broad TB control strategy, DOTS also includes drug supply, monitoring and case detection based on microscopy. Directly observed treatment (DOT), as opposed to DOTS, refers to the treatment component alone.